Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 7.

Journal Article

Bacher, R., Dietlein, M., Kobe, C., Hohberg, M., Wild, M., Drzezga, A. and Schmidt, M. (2018). Retrospective comparison of thyroid and whole-body residence time of radioiodine in patients with differentiated thyroid carcinoma at initial ablative radioiodine therapy and follow-up whole-body scintigraphy after a short period of hypothyroidism or under rhTSH stimulation. Eur. J. Nucl. Med. Mol. Imaging, 45. S. S606 - 2. NEW YORK: SPRINGER. ISSN 1619-7089

Hammes, J., Hohberg, M., Taeger, P., Wild, M., Zlatopolskiy, B., Krapf, P., Neumaier, B., Schomaecker, K., Kobe, C., Schmidt, M., Dietlein, M. and Drzezga, A. (2018). Uptake In Non-affected Bone Tissue Does Not Differ Between [18f]-DCFPyL And [68Ga]-HBED-CC PSMA PET/CT. Eur. J. Nucl. Med. Mol. Imaging, 45. S. S535 - 1. NEW YORK: SPRINGER. ISSN 1619-7089

Hohberg, M., Dietlein, M., Kobe, C., Dietlein, F., Zlatopolskiy, B., Krapf, P., Wild, M., Taeger, P., Neumaier, B. and Drzezga, A. (2018). Biodistribution and radiation dosimetry of the novel F-18-labeled prostate-specific membrane antigen-ligand PSMA-7 for PET/CT in prostate cancer patients. Eur. J. Nucl. Med. Mol. Imaging, 45. S. S149 - 2. NEW YORK: SPRINGER. ISSN 1619-7089

Hohberg, M., Eschner, W., Schmidt, M., Dietlein, M., Kobe, C., Fischer, T., Drzezga, A. and Wild, M. (2016). Radiation dosimetry of organs and tissues at risk from Lu-177-DKFZ-PSMA-617 for prostate cancer therapy. Eur. J. Nucl. Med. Mol. Imaging, 43. S. S414 - 2. NEW YORK: SPRINGER. ISSN 1619-7089

Hohberg, M., Kobe, C., Taeger, P., Hammes, J., Schmidt, M., Dietlein, F., Wild, M., Heidenreich, A., Drzezga, A. and Dietlein, M. (2019). Combined Early and Late [Ga-68]PSMA-HBED-CC PET Scans Improve Lesion Detectability in Biochemical Recurrence of Prostate Cancer with Low PSA Levels. Mol. Imaging. Biol., 21 (3). S. 558 - 567. NEW YORK: SPRINGER. ISSN 1860-2002

Reifegerst, M., Hohberg, M., Hammes, J., Drzezga, A. and Wild, M. (2018). LuISA - Lu-177-PSMA intelligent szintigraphy application. Eur. J. Nucl. Med. Mol. Imaging, 45. S. S225 - 2. NEW YORK: SPRINGER. ISSN 1619-7089

Taeger, P. A., Hammes, J., Hohberg, M., Wild, M., Schomaecker, K., Kobe, C., Pfister, D., Heidenreich, A., Dietlein, M., Schmidt, M. and Drzezga, A. (2018). Discrete evaluation of multi-cycle Lu-177-PSMA-617-therapy effects on bone versus lymph node metastases in patients with metastasized castrationresistant prostate cancer (mCRPC). Eur. J. Nucl. Med. Mol. Imaging, 45. S. S126 - 1. NEW YORK: SPRINGER. ISSN 1619-7089

This list was generated on Fri Oct 15 05:36:56 2021 CEST.